Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-02-10 08:08 am Sale | 13G | UNUM THERAPEUTICS INC UMRX | Sanofi SNY | 842,048 2.75% | -931,433 (-52.52%) | View |
| 2020-02-10 08:07 am Sale | 13G | REGULUS THERAPEUTICS INC RGLS | Sanofi SNY | 0 0% | -8,706,526 (Position Closed) | View |
| 2020-02-10 07:34 am Purchase | 13G | SANOFI-ADR SNY | BlackRock Inc. BLK | 81,902,285 6.5% | 3,993,323 (+5.13%) | View |
| 2019-12-09 5:00 pm Sale | 13D | REGENERON PHARMACEUTICALS INC REGN | Sanofi SNY | 23,350,365 21.6% | -530,172 (-2.22%) | View |
| 2019-07-29 10:13 am Purchase | 13G | FULCRUM THERAPEUTICS INC FULC | Sanofi SNY | 558,035 2.4% | 558,035 (New Position) | View |
| 2019-05-03 4:02 pm Sale | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | Sanofi SNY | 0 0% | -10,554,134 (Position Closed) | View |